RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis.
Several viruses are causing illnesses in Ohio and the U.S. See the symptoms for COVID-19, RSV, flu, norovirus and bird flu.
Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...
For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.
The CDC reports that influenza A, COVID-19, norovirus, and RSV are on the rise this winter, with symptoms such as fever, ...
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...
RSV causes respiratory symptoms ranging from mild, cold-like discomfort to illnesses like bronchiolitis or pneumonia ...
The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...
Wisconsin DHS Respiratory Disease Epidemiologist Thomas Haupt told the Journal Sentinel in an email the department's most recent data indicates the state has "moderate RSV activity" but noted it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback